Microarrays Inc. specializes in advanced microarray technologies, particularly through their MI PathArray platform, which is designed for focused gene expression analysis. This platform allows researchers to explore specific biological pathways related to development and disease, providing a cost-effective alternative to traditional whole-genome microarrays and qPCR methods. The MI PathArray features a collection of pathway-specific probes, with each slide containing four identical arrays that enhance sensitivity and statistical power. The platform supports semi-quantitative analysis by utilizing spike-in controls and offers flexibility in assay formats, making it compatible with various hybridization systems.

In addition to the MI PathArray, Microarrays Inc. also provides protein and antibody arrays that expand research capabilities into proteomics. These resources are designed to facilitate the exploration of new areas in biological research, complementing the gene expression analysis offered by the MI PathArray. The company emphasizes the importance of continual updates to their probe collections, ensuring that researchers have access to the most relevant and scientifically validated content for their studies. Overall, Microarrays Inc. aims to support researchers with high-quality, reliable tools for gene and protein analysis, enhancing the understanding of complex biological processes.

United States

Microarrays is a biotechnology company that offers array products for biological research, detection, and diagnostics, focusing on advancing array-based technologies.

Microarrays Inc

Company Details